Cargando…
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
Immune checkpoint inhibitors (ICIs) have become a promising immunotherapy for cancers. Human leukocyte antigen-G (HLA-G), a neoantigen, its biological functions and clinical relevance have been extensively investigated in malignancies, and early clinical trials with “anti-HLA-G strategy” are being l...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278316/ https://www.ncbi.nlm.nih.gov/pubmed/34276691 http://dx.doi.org/10.3389/fimmu.2021.698677 |